Lung Cancer

       　肺癌是一种常见的肺部恶性肿瘤，绝大多数肺癌起源于支气管粘膜上皮，近年来，随着吸烟和各种环境因素的影响,世界各国特别是工业发达国家，肺癌的发病率和病死率均迅速上升。每年11月是“全球肺癌关注月”。为此CMBI特准备了关于lung的相关文献，供大家参考。更多文献，请用相关关键词通过CMBI文献查询获取。

• 4-year mortality in patients with non-small-cell lung cancer
  
• Predicting the outcome of chemotherapy for lung cancer
  
• Cytogenetic and molecular aspects of lung cancer
  
• A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
  
• Predicting the outcome of chemotherapy for lung cancer
  
• Epigenetics of lung cancer
  
• Early detection and chemoprevention of lung cancer
  
• critical appraisal of prognostic and predictive factors for common lung cancers
  
• Where next for gefitinib in patients with lung cancer
  
• Proteasome inhibitors in lung cancer
  
• MKP1-CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
  
• Lung Cancer Screening
  
• Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)
  
• EGF receptor mutations in lung cancer
  
• Cell cycle regulation and its aberrations in human lung carcinoma
  
• The Future in Diagnosis and Staging of Lung Cancer
  
• Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
  
• Second-line treatment for advanced non-small cell lung cancer
  
• Screening for lung cancer
  
• An Update on the Role of Epidermal Growth Factor receptor Inhibitors in Non–Small Cell Lung Cancer
  
• Non–Small Cell Lung Cancer
  
• Use of Novel Second-Line Targeted Therapies in Non–Small Cell Lung Cancer
  
• Targeting Angiogenesis in Lung Cancer
  
• Second-Line Treatment Options in Non–Small Cell Lung Cancer
  
• Second-Line Treatment Options in Advanced Non–Small Cell Lung Cancer
  
• Role of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors
  
• Other Compounds and Targets in Non–Small Cell Lung Cancer
  
• Optimizing Therapy in Previously Treated Non–Small Cell Lung Cancer
  
• Ongoing First-Line Studies of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
  
• Geographic Variation in the Second-Line Treatment of Non–Small Cell Lung Cancer
  
• Future Directions in the Second-Line Treatment of Non–Small Cell Lung Cancer
  
• Emergence of a Unique Population in Non–Small Cell Lung Cancer
  
• Non-small-cell lung cancer in the elderly
  
• Non-small-cell lung cancer and breast carcinoma-chemotherapy
  
• Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes
  
• Lung cancer, a new challenge in the HIV-infected population
  
• epidemiologic study of early onset lung cancer
  
• Early Detection of Lung Cancer
  
• Does high intake of fruit and vegetables improve lung cancer
  
• Critical review of PET-CT for radiotherapy planning in lung cancer
  
• Cochrane systematic reviews of treatments for lung cancer
  
• Chemoradiation paradigm for the treatment of lung cancer
  
• Angiogenesis in non-small cell lung cancer
  
• Adjuvant chemotherapy for completely resected non-small cell lung cancer
  
• Non-small-cell lung cancer in the elderly
  
• Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer
  
• Update in screening of lung cancer
  
• The size of mediastinal lymph nodes and its relation with metastatic involvement